ANGIOGENESIS AS A MORPHOLOGICAL MARKER OF TUMOR GROWTH: AN ANALYSIS OF CURRENT LITERATURE DATA

Автор(и)

  • Ihor Zabrodskyi Автор
  • Tetiana Pankiv Автор
  • Tatiana Khmara Автор

DOI:

https://doi.org/10.65237/2336-3630-2026-2(2)-17

Ключові слова:

angiogenesis, tumor growth, vascular endothelial growth factor (VEGF), tumor, pathomorphology

Анотація

Introduction. The issue of tumor growth remains one of the most pressing challenges in contemporary biomedical science due to the high prevalence of oncological diseases and the complexity of their pathogenesis. Angiogenesis ensures tumor vascularization, oxygen and nutrient supply, and contributes to invasion and metastasis, while its morphological manifestations are used to assess tumor progression and prognosis.

The aim of study was to analyze and summarize current literature data on angiogenesis as a morphological marker of tumor growth.

Results. Analysis of recent publications shows that tumor angiogenesis occurs through classical formation of new blood vessels (sprouting) as well as alternative mechanisms such as vessel co-option and vasculogenesis. VEGF plays a central role, with its activity correlating with increased microvascular density and poor prognosis. Perivascular spaces, cells of the tumor microenvironment, and tumor-associated macrophages play important regulatory roles, stimulating the formation of pathological vascular networks and increasing tumor invasiveness. Metabolic and epigenetic mechanisms (e.g., m6A RNA modifications) additionally influence the intensity of angiogenesis, as well as the structure and architecture of the tumor vascular network, allowing assessment of its growth dynamics, degree of aggressiveness, and morphological changes.

Conclusions. Angiogenesis is a universal and multifaceted morphological marker of tumor growth, reflecting the integration of molecular, cellular, and tissue-level processes. Further research should focus on understanding these mechanisms in greater detail to improve tumor characterization and prognostic assessment.

References

1.              World Health Organization. (2025). Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer

2.              Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today

3.              Zhang, R., Yao, Y., Gao, H., & Hu, X. (2024). Mechanisms of angiogenesis in tumour. Frontiers in Oncology, 14, 1359069. Available from: https://doi.org/10.3389/fonc.2024.1359069

4.              Ribatti, D., Annese, T., & Tamma, R. (2023). Vascular co-option in resistance to anti-angiogenic therapy. Frontiers in oncology, 13, 1323350. Available from: https://doi.org/10.3389/fonc.2023.1323350

5.              Belotti, D., Pinessi, D., & Taraboletti, G. (2021). Alternative Vascularization Mechanisms in Tumor Resistance to Therapy. Cancers, 13(8), 1912. Available from: https://doi.org/10.3390/cancers13081912

6.              Gamde, S. M., & Ogenyi, O. D. (2024). Angiogenesis in breast cancer: A review. Asian Pac J Cancer Biol, 9 (1), 97-103. Available from: https://doi.org/10.31557/apjcb.2024.9.1.97-103

7.              Liu, Z. L., Chen, H. H., Zheng, L. L., Sun, L. P., & Shi, L. (2023). Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal transduction and targeted therapy, 8(1), 198. Available from: https://doi.org/10.1038/s41392-023-01460-1

8.              Liu, X., Zhang, J., Yi, T., Li, H., Tang, X., Liu, D., ... & Li, Y. (2025). Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies. Biomarker Research, 13(1), 62. Available from: https://doi.org/10.1186/s40364-025-00779-x

9.              Zhou, J., Zhou, P., Wang, J., & Song, J. (2024). Roles of endothelial cell specific molecule1 in tumor angiogenesis. Oncology Letters, 27(3), 137. Available from: https://doi.org/10.3892/ol.2024.14270

10.          Qin, L., Zeng, X., Qiu, X., Chen, X., & Liu, S. (2024). The role of N6-methyladenosine modification in tumor angiogenesis. Frontiers in Oncology, 14, 1467850. Available from: https://doi.org/10.3389/fonc.2024.1467850

11.          Arce-Recatala, C., & Oberkersch, R. E. (2025). Endothelial Arginine Metabolism in Angiogenesis: Mechanistic Insights from Tissue Repair to Tumor Progression. Metabolites, 15(11), 694. Available from: https://doi.org/10.3390/metabo15110694

12.          Qiao, X., Song, Z., Geng, L., Xing, L., & Wang, Y. (2025). Investigating the role of tumor cell heterogeneity and angiogenesis genes in the prognosis of multiple myeloma. Frontiers in Immunology, 16, 1610833. Available from: https://doi.org/10.3389/fimmu.2025.1610833

13.          Zabrodskyi I. S., Protsak T. V. Rol peryvaskuliarnykh prostoriv (prostory Virkhova—Robina) u rehuliatsii anhiogenezu v mozku. Mizhdystsyplinarni naukovi doslidzhennia ta perspektyvy yikh rozvytku: materialy VIII Mizhnarodnoi studentskoi naukovoi konferentsii, m. Ivano-Frankivsk, 30 sichnia, 2026 rik / HO «Molodizhna naukova liha». — Vinnytsia: TOV «UKRLOGOS Hrup», 2026. S. 242–244.

14.          Demir, E., Montgomery, D., Saloum, A., Yaghi, N., & Karsy, M. (2025). Current Understanding Regarding the Glioma Microenvironment and Impact of the Immune System. Neuroglia, 6(1), 13. https://doi.org/10.3390/neuroglia6010013

15.          Ravin, R., Suarez-Meade, P., Busse, B., Blank, P. S., Vivas-Buitrago, T., Norton, E. S., ... & Quiñones-Hinojosa, A. (2023). Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain. Journal of neuro-oncology, 164(1), 43-54. https://doi.org/10.1007/s11060-023-04349-9

16.          Mosteiro, A., Pedrosa, L., Ferrés, A., Diao, D., Sierra, À., & González, J. J. (2022). The Vascular Microenvironment in Glioblastoma: A Comprehensive Review. Biomedicines, 10(6), 1285. https://doi.org/10.3390/biomedicines10061285

17.          Zhang, R., Yao, Y., Gao, H., & Hu, X. (2024). Mechanisms of angiogenesis in tumour. Frontiers in Oncology, 14, 1359069. https://doi.org/10.3389/fonc.2024.1359069

18.          Mohseni, A., Pooyan, M., Raiesdana, S., & Menhaj, M. B. (2024). The Effect of Tumor Angiogenesis Agents on Tumor Growth Dynamics: A Mathematical Model. Frontiers in Biomedical Technologies. Available from: https://doi.org/10.18502/fbt.v12i1.17743

19.          Venketesh K. Panda and Sumant K. Mohanty (2025) Deciphering the Role of Tumor-Associated Macrophages (Tams) in Tumor Angiogenesis. J of Clin Onco & Adv Thpy 1(2), 01-08. Available from: https://doi.org/10.63721/25JCOAT0104

20.          Pang, L., Liu, S., Liu, C., Hu, S., Zhang, Z., & Tian, T. (2025). Dynamic modeling and analysis of tumor angiogenesis and anti-angiogenesis treatment. Journal of Biological Systems, 33(02), 647-667. Available from: https://doi.org/10.1142/S0218339025500172

Біографії авторів

Завантаження

Опубліковано

2026-02-21

Номер

Розділ

Статті